Jio Platforms' ₹30,213 crore IPO was fully subscribed within 100 minutes of opening on October 21. The issue was booked 22.19 times, with strong institutional demand driving the bids.
Sahajanand Medical Technologies' debut was broadly in line with grey market premium (GMP) indications, which had pointed to listing gains of around 8 per cent.
Analysts attribute the strong performance of recent IPOs to investor preference for niche and differentiated businesses, backed by healthy growth expectations and high entry barriers in some segments.
Zetwerk IPO review: Brokerages have shared mixed views on the public issue. SBI Securities and ICICI Direct have recommended a 'Subscribe' rating, while Swastika has rated it 'Neutral'.
Jio IPO GMP today: On Thursday morning, Jio Platforms shares traded at ₹1,319 in the grey market, implying a premium of ₹200 per share, or 17.87 per cent over the upper end of the price band.
Fusion CX IPO review: Brokerages have shared mixed ratings on Fusion CX Ltd IPO. SBI Securities has recommended 'Subscribe' rating, while Swastika has rated it 'Neutral'.
The key concern for the investors in mega issues, according to G Chokkalingam, founder and head of research at Equinomics Research, is how the issue is priced.
SS Retail, Jindal Supreme and Hero Motors IPOs were available for bidding from September 16 to September 18, with listings slated to take place on BSE and NSE.
NSE IPO subscription status, GMP today: NSE has set a price band of ₹1,700-1,785 per share, with a face value of ₹ 1. In the grey market, NSE shares are trading at a premium of up to 9 per cent.
LCC Projects IPO: LCC's profitability metrics, decent valuations and improving debt profile propel analysts to assign a 'subscribe for long-term' rating to the IPO.